In vitro susceptibility of Actinobaculum schaalii to mecillinam

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2181-2182

  Andersen, Pernille Kræmer ^a   Søby, Karen Marie ^a   Bank, Steffen ^a   Prag, Jørgen ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

A. schaalii; Antimicrobial susceptibility; Emerging uropathogen; UTIs

Indexed keywords

MECILLINAM; PIVMECILLINAM;

ACTINOBACULUM SCHAALII; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

ACTINOMYCETACEAE; ACTINOMYCETALES INFECTIONS; AMDINOCILLIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 80051706050     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr270     Document Type: Letter

References (7)

1. Lawson PA, Falsen E, Å kervall E et al. Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol 1997; 47: 899-903.
2. Reinhard M, Prag J, Kemp M et al. Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility. J Clin Microbiol 2005; 43: 5305-8.
3. Bank S, Jensen A, Hansen TM et al. Actinobaculum schaalii, a common uropathogeninelderly patients, Denmark. Emerg Infect Dis 2010;16: 76-80.
4. Nielsen HL, Søby KM, Christensen JJ et al. Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Scand J Infect Dis 2010; 42: 43-7.
5. Cattoir V, Varca A, Greub G et al. In vitro susceptibility of Actinobaculumschaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. J Antimicrob Chemother 2010; 65: 2514-7.
6. Graninger W. Pivmecillinam - therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 2003; 22: 73-8.
7. Danish Medicines Agency. Annual Statistics of Medicinal Products and Medicinal Product Groups, 2005-2009. http://www.medstat.dk/ (21 March 2011, date last accessed).